Literature DB >> 20650672

Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries.

Julia Henry1, Richard J Smeyne, Haeman Jang, Bayard Miller, Michael S Okun.   

Abstract

PURPOSE: Given the recent paper by Jang et al. on "A Highly Pathogenic H5N1 Influenza Virus" which reported a novel animal model of parkinsonism, we aimed to perform a complete historical review of the 20th and 21st century literature on parkinsonism and neurological manifestations of influenza. SCOPE: There were at least twelve major flu pandemics reported in the literature in the 20th and 21st century. Neurological manifestations most prevalent during the pandemics included delirium, encephalitis, ocular abnormalities, amyotrophy, myelopathy, radiculopathy, ataxia and seizures. Very little parkinsonism was reported with the exception of the 1917 cases originally described by von Economo.
CONCLUSIONS: To date there have been surprisingly few cases of neurological issues inclusive of parkinsonism associated with influenza pandemics. Given the recent animal model of H5N1 influenza associated parkinsonism, the medical establishment should be prepared to evaluate for the re-emergence of parkinsonism during future outbreaks.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20650672      PMCID: PMC4684089          DOI: 10.1016/j.parkreldis.2010.06.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  40 in total

1.  Neurological and hepatic disorders associated with influenza.

Authors:  C C KAPILA; S KAUL; S C KAPUR; T S KALAYANAM; D BANERJEE
Journal:  Br Med J       Date:  1958-11-29

2.  Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920.

Authors:  K C Lo; J F Geddes; R S Daniels; J S Oxford
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

3.  Influenza: historical aspects of epidemics and pandemics.

Authors:  Burke A Cunha
Journal:  Infect Dis Clin North Am       Date:  2004-03       Impact factor: 5.982

4.  Discussion on Influenza.

Authors:  E B Turner
Journal:  Proc R Soc Med       Date:  1919

5.  Influenza and its complications. II.

Authors:  C H Stuart-Harris
Journal:  Br Med J       Date:  1966-01-22

6.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Authors:  E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

7.  Influenza caused epidemic encephalitis (encephalitis lethargica): the circumstantial evidence and a challenge to the nonbelievers.

Authors:  C P Maurizi
Journal:  Med Hypotheses       Date:  2010-01-08       Impact factor: 1.538

8.  Aneurysmal subarachnoid hemorrhage and viral infection. Lack of association.

Authors:  T A Timmons; G A Donnan; J P Whisnant; C D Shelley; T F Smith
Journal:  Arch Neurol       Date:  1986-04

9.  The substantia nigra is a major target for neurovirulent influenza A virus.

Authors:  M Takahashi; T Yamada; S Nakajima; K Nakajima; T Yamamoto; H Okada
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more
  39 in total

1.  Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.

Authors:  Aaron T Phillips; Amber B Rico; Charles B Stauft; Sean L Hammond; Tawfik A Aboellail; Ronald B Tjalkens; Ken E Olson
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

Review 2.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

3.  Part I: The 1918 Influenza in Missouri: Centennial Remembrance of the Crisis.

Authors:  David S McKinsey; Joel P McKinsey; Maithe Enriquez
Journal:  Mo Med       Date:  2018 May-Jun

4.  The Impact of Non-Neurotropic Influenza Strains on the Brain: A Role for Microglial Priming?

Authors:  Maria Carolina Barbosa-Silva; Luís Eduardo Santos; Bárbara Rangel
Journal:  J Neurosci       Date:  2018-09-05       Impact factor: 6.167

5.  Long-lasting transcriptional refractoriness triggered by a single exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine.

Authors:  R Pattarini; Y Rong; K R Shepherd; Y Jiao; C Qu; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2012-04-24       Impact factor: 3.590

6.  CNS infections, sepsis and risk of Parkinson's disease.

Authors:  Fang Fang; Karin Wirdefeldt; Andreas Jacks; Freya Kamel; Weimin Ye; Honglei Chen
Journal:  Int J Epidemiol       Date:  2012-04-19       Impact factor: 7.196

Review 7.  Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.

Authors:  Hui-Ming Gao; Jau-Shyong Hong
Journal:  Prog Neurobiol       Date:  2011-03-23       Impact factor: 11.685

8.  Influenza-associated global amnesia and hippocampal imaging abnormality.

Authors:  Jonathan Lopez; Catherine Lomen-Hoerth; Gayle K Deutsch; Geoffrey A Kerchner; Anita Koshy
Journal:  Neurocase       Date:  2013-05-22       Impact factor: 0.881

Review 9.  Spectrum of Movement Disorders in Patients With Neuroinvasive West Nile Virus Infection.

Authors:  Abhishek Lenka; Anuja Kamat; Shivam Om Mittal
Journal:  Mov Disord Clin Pract       Date:  2019-07-16

10.  Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.

Authors:  Wei Wang; Linh T T Nguyen; Christopher Burlak; Fariba Chegini; Feng Guo; Tim Chataway; Shulin Ju; Oriana S Fisher; David W Miller; Debajyoti Datta; Fang Wu; Chun-Xiang Wu; Anuradha Landeru; James A Wells; Mark R Cookson; Matthew B Boxer; Craig J Thomas; Wei Ping Gai; Dagmar Ringe; Gregory A Petsko; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.